Fusion and flow: refining risk prediction in KMT2A-rearranged pediatric acute myeloid leukemia

Transl Pediatr. 2023 Dec 26;12(12):2099-2102. doi: 10.21037/tp-23-436. Epub 2023 Nov 30.

Authors

Shannon E Conneely¹, Rachel E Rau²

Affiliations

¹ Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX, USA.
² Department of Pediatrics and the Ben Towne Center for Childhood Cancer Research, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.

No abstract available

Keywords: Acute myeloid leukemia (AML); KMT2A rearranged; measurable residual disease; risk stratification.

Publication types

Editorial
Comment